지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술대회자료
- 저자정보
- 발행연도
- 2021.6
- 수록면
- 38 - 39 (2page)
이용수
초록· 키워드
오류제보하기
Pancreatic cancer is the seventh leading cause of cancer-related death worldwide. The overall 5-year survival rate is less than 6% due to late clinical manifestations and the systemic nature of the disease at presentation. Although surgery is the only curative treatment option for resectable disease, 5-year survival rates after resection remain poor between at 15 and 30%.
Borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC) are anatomically characterised by the involvement extent of major vessels, which is likely associated with positive resection margin.5 BRPC has been regarded as a potentially curative disease, and neoadjuvant therapy may lead to improvements in R0 resection rates and long-term survival. Although there is no evidence based on randomised Phase 3 trials investigating BRPC or LAPC, conven^_@span style=color:#999999 ^_# ... ^_@/span^_#^_@a href=javascript:; onclick=onClickReadNode('NODE10593426');fn_statistics('Z354','null','null'); style='color:#999999;font-size:14px;text-decoration:underline;' ^_#전체 초록 보기^_@/a^_#
Borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC) are anatomically characterised by the involvement extent of major vessels, which is likely associated with positive resection margin.5 BRPC has been regarded as a potentially curative disease, and neoadjuvant therapy may lead to improvements in R0 resection rates and long-term survival. Although there is no evidence based on randomised Phase 3 trials investigating BRPC or LAPC, conven^_@span style=color:#999999 ^_# ... ^_@/span^_#^_@a href=javascript:; onclick=onClickReadNode('NODE10593426');fn_statistics('Z354','null','null'); style='color:#999999;font-size:14px;text-decoration:underline;' ^_#전체 초록 보기^_@/a^_#
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
-
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
-
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
-
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
-
A phase 2 trial of neoadjuvant modified folfirinox chemotherapy for resectable pancreatic adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
-
Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer
Annals of Surgical Treatment and Research
2017 .10
-
[Hapato-Biliary and Pancreas] Prognostic Nomogram Considering Pathology and Biologic Parameters for Resected Borderline Resectable and Locally Advanced Pancreatic Cancer (BRPC & LAPC) Following Neoadjuvant Chemotherapy
대한외과학회 학술대회 초록집
2022 .11
-
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
-
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
-
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
-
국소 진행성 췌장암에서의 내시경적 국소 치료
대한췌담도학회지
2020 .01
-
Could computed tomography predict vascular R0 resection in patients with borderline and locally advanced pancreatic adenocarcinoma after neoadjuvant chemotherapy?
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Evaluation of the effect of neoadjuvant treatment in pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2019 .05
-
The decrease or normalization of carbohydrate antigen 19-9 have comparable prognostic performance in patients with borderline resectable and locally advanced pancreatic cancer after neoadjuvant chemotherapy
대한외과학회 학술대회 초록집
2019 .10
-
Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
Gut and Liver
2022 .01
-
Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-analysis
대한외과학회 학술대회 초록집
2022 .11
-
Comments on - Neoadjuvant Chemo-radiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-514-001918968